308 results match your criteria: "Williams Institute[Affiliation]"
Int J Mol Sci
January 2025
The Roger Williams Institute of Liver Studies, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London & Foundation for Liver Research, London SE5 9NT, UK.
Bacterial translocation-induced inflammation and immune dysfunction are recognised factors contributing to the pathogenesis of primary biliary cholangitis (PBC). However, the specific involvement of interferons (IFNs) and soluble checkpoints (sol-CRs) in shaping the immune landscape in PBC patients remains unexplored. Furthermore, the influence of ursodeoxycholic acid (UDC) on these immune mediators is unknown.
View Article and Find Full Text PDFNPJ Antimicrob Resist
June 2024
Science Research and Innovation, Medicines and Healthcare products Regulatory Agency, Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK.
Antimicrobial resistance is a global threat to public health. Without proactive intervention, common infections may become untreatable, restricting the types of clinical intervention that can be undertaken and reversing improvements in mortality rates. Effective antimicrobial stewardship represents one approach to restrict the spread of antimicrobial resistance but relies on rapid and accurate diagnostics that minimise the unnecessary use of antibiotics.
View Article and Find Full Text PDFPediatr Transplant
February 2025
Roger Williams Institute of Hepatology, King's College London, London, UK.
Liver Int
February 2025
Roger Williams Institute of Liver Studies, Foundation for Liver Research, London, UK.
Background: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) encompasses a spectrum of histological conditions ranging from simple steatosis to fibrosing steatohepatitis, and is a risk factor for cardiovascular diseases (CVD). While oxidised apolipoproteins A and B have been linked to obesity and CVD, the association between other oxidised apolipoproteins and MASLD is yet to be established. To fill this gap, we characterised the circulating serum peptidome of patients with MASLD.
View Article and Find Full Text PDFAIDS Behav
December 2024
University of Washington Addictions, Drug & Alcohol Institute, Department of Psychiatry and Behavioral Sciences, Seattle, WA, USA.
In Southern U.S. states with high HIV incidence and low HIV Pre-Exposure Prophylaxis (PrEP) uptake, enhanced efforts to increase interest in and willingness to use PrEP are needed.
View Article and Find Full Text PDFNutr Metab (Lond)
December 2024
Department of Interdisciplinary Medicine, Clinica Medica "C. Frugoni", "Aldo Moro" University of Bari, Piazza Giulio Cesare 11, 70124, Bari, Italy.
Steatotic liver disease (SLD) and Hepatocellular Carcinoma (HCC) are characterised by a substantial rewiring of lipid fluxes caused by systemic metabolic unbalances and/or disrupted intracellular metabolic pathways. SLD is a direct consequence of the interaction between genetic predisposition and a chronic positive energy balance affecting whole-body energy homeostasis and the function of metabolically-competent organs. In this review, we discuss how the impairment of the cross-talk between peripheral organs and the liver stalls glucose and lipid metabolism, leading to unbalances in hepatic lipid fluxes that promote hepatic fat accumulation.
View Article and Find Full Text PDFJ Hepatol
December 2024
Roger Williams Institute of Studies, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Womens Health Issues
December 2024
Williams Institute, UCLA, Los Angeles, California.
Purpose: Research has demonstrated that sexual minority populations are more likely to experience poverty than sexual majority populations and that many of these disparities are driven by specific sexual minority subgroups, including cisgender bisexual women. Yet, little is known about the factors associated with economic insecurity that explain the intragroup differences in economic outcomes among sexual minorities, particularly among those of the same gender (i.e.
View Article and Find Full Text PDFJ Hepatol
November 2024
CHRU de Lille, Hôpital Claude Huriez, Rue M. Polonovski CS 70001, 59 037 Lille Cedex, France. Electronic address:
In this position statement, we explore the intricate relationship between alcohol intake and metabolic dysfunction in the context of the 2023 nomenclature update for steatotic liver disease (SLD). Recent and lifetime alcohol use should be accurately assessed in all patients with SLD to facilitate classification of alcohol use in grams of alcohol per week. Alcohol biomarkers (i.
View Article and Find Full Text PDFNat Rev Gastroenterol Hepatol
January 2025
Roger Williams Institute of Liver Studies, Foundation for Liver Research, London, UK.
NIHR Open Res
October 2024
Therapy Services, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Background: Alcohol use is the third leading risk factor of death and disability in the UK and costs the NHS £3.5 billion per year. Despite the high prevalence and healthcare burden of Alcohol-related Liver Disease (ArLD), there has been minimal research addressing prevention, morbidity and mortality.
View Article and Find Full Text PDFAm J Public Health
December 2024
Nicole F. Kahn is with the Division of Adolescent Medicine, Department of Pediatrics, School of Medicine, University of Washington, Seattle; Center for Child Health, Behavior and Development, Seattle Children's Research Institute; and Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill. Carolyn T. Halpern is with the Department of Maternal and Child Health, Gillings School of Global Public Health; and Carolina Population Center, University of North Carolina at Chapel Hill. Dana R. Burshell is with the Carolina Population Center. Stephanie M. Hernandez is with the Department of Epidemiology and Biostatistics, Dornsife School of Public Health, Drexel University, Philadelphia, PA; Department of Maternal and Child Health, Gillings School of Global Public Health; and Carolina Population Center. Kerith J. Conron is with the Williams Institute, School of Law, University of California Los Angeles, and Carolina Population Center.
J Hepatol
October 2024
Roger Williams Institute of Liver Studies, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, United Kingdom. Electronic address:
Commun Med (Lond)
October 2024
Department of Medical Physics and Biomedical Engineering, University College London, London, WC1E 6BT, UK.
Background: The thymus, responsible for T cell-mediated adaptive immune system, has a structural and functional complexity that is not yet fully understood. Until now, thymic anatomy has been studied using histological thin sections or confocal microscopy 3D reconstruction, necessarily for limited volumes.
Methods: We used Phase Contrast X-Ray Computed Tomography to address the lack of whole-organ volumetric information on the microarchitecture of its structural components.
Aliment Pharmacol Ther
December 2024
Sorbonne Université, Institute for Cardiometabolism and Nutrition, Hospital Pitié-Salpêtrière, INSERM UMRS 1138 CRC, Paris, France.
Background: Semaglutide, a glucagon-like peptide-1 receptor agonist, has demonstrated potential beneficial effects in metabolic dysfunction-associated steatohepatitis (MASH).
Aims: To describe the trial design and baseline characteristics of the 'Effect of Semaglutide in Subjects with Non-cirrhotic Non-alcoholic Steatohepatitis' (ESSENCE) trial (NCT04822181).
Methods: ESSENCE is a two-part, phase 3, randomised, multicentre trial evaluating the effect of subcutaneous semaglutide 2.
Am J Physiol Gastrointest Liver Physiol
January 2025
Gubra, Hørsholm, Denmark.
Sci Rep
October 2024
Institute of Liver Studies, King's College Hospital, Denmark Hill, London, SE5 9RS, UK.
Sci Rep
October 2024
Institute for Bioengineering, School of Engineering, University of Edinburgh, Edinburgh, UK.
Liver disease cases are rapidly expanding worldwide, and transplantation remains the only effective cure for end-stage disease. There is an increasing demand for developing potential drug treatments, and regenerative therapies using in-vitro culture platforms. Human decellularized extracellular matrix (dECM) is an appealing alternative to conventional animal tissues as it contains human-specific proteins and can serve as scaffolding materials.
View Article and Find Full Text PDFElife
October 2024
Roger Williams Institute of Liver Studies, Faculty of Life Sciences and Medicine, King's College London and King's College Hospital, London, United Kingdom.
Nat Rev Gastroenterol Hepatol
November 2024
UCM Digestive Diseases, Virgen del Rocío University Hospital. Instituto de Biomedicina de Sevilla (HUVR/CSIC/US), Department of Medicine, University of Seville, Seville, Spain.
Int J Mol Sci
August 2024
The Roger Williams Institute of Hepatology, Foundation for Liver Research, 111 Coldharbour Lane, London SE5 9NT, UK.
The global burden of liver cancer is increasing. Timely diagnosis is important for optimising the limited available treatment options. Understanding the metabolic consequences of hepatocellular carcinoma (HCC) may lead to more effective treatment options.
View Article and Find Full Text PDFClin Gastroenterol Hepatol
August 2024
Division of Digestive Diseases, Imperial College London, London, United Kingdom. Electronic address:
Background And Aims: Short-term mortality in alcohol-related hepatitis (AH) is high, and no current therapy results in durable benefit. A role for interleukin (IL)-1β has been demonstrated in the pathogenesis of alcohol-induced steatohepatitis. This study explored the safety and efficacy of canakinumab (CAN), a monoclonal antibody targeting IL-1β, in the treatment of patients with AH.
View Article and Find Full Text PDFJ Grad Med Educ
August 2024
is Professor and Associate Dean for Graduate Medical Education, Vanderbilt School of Medicine, Nashville, Tennessee, USA.
Aliment Pharmacol Ther
October 2024
Liver Failure Group, UCL Institute for Liver and Digestive Health, UCL Medical School, London, UK.
Background: Apart from direct portal pressure reduction, non-selective beta-blockers (NSBB) modulate inflammatory response, which could be beneficial in patients with acute decompensation (AD). We therefore aimed to evaluate the effect of NSBB on 28-day mortality and markers of systemic inflammation in a propensity score-matched (PSM) cohort of AD patients requiring intensive care unit (ICU) admission.
Methods: Patients were recruited from registry of AD patients requiring ICU admission.
J Miss State Med Assoc
June 2024
Department of Population Health Science, John D. Bower School of Population Health, University of Mississippi Medical Center.